Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
20.96
+0.71 (3.51%)
At close: Jun 26, 2026, 4:00 PM EDT
21.17
+0.21 (0.98%)
After-hours: Jun 26, 2026, 7:54 PM EDT

Adaptive Biotechnologies Operating Metrics

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
115.07K 105.59K 96.49K 88.98K 82.18K 76.11K 70.84K 66.31K
Number of Clonoseq Tests Delivered Growth
40.01% 38.74% 36.21% 34.19% 33.72% 34.71% 37.98% 44.41%

Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
235.71M 212.33M 190.60M 171.28M 156.62M 145.53M 136.14M 123.34M
MRD Growth
50.49% 45.90% 40.00% 38.87% 37.46% 41.65% 36.03% 29.33%
Immune Medicine
59.70M 64.64M 62.16M 33.94M 32.90M 33.43M 41.14M 45.43M
Immune Medicine Growth
81.45% 93.38% 51.09% -25.29% -45.67% -50.50% -48.32% -51.79%

Immune Medicine Revenue Breakdown
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Collaboration
37.68M 41.28M 44.78M 14.55M 12.36M 13.45M 17.87M 22.37M
Collaboration Growth
204.77% 206.88% 150.58% -34.98% -67.59% -68.41% -64.93% -65.19%
Immune Medicine Service
22.02M 23.36M 17.38M 19.39M 20.54M 19.98M 23.27M 23.06M
Immune Medicine Service Growth
7.21% 16.94% -25.31% -15.89% -8.37% -19.96% -18.79% -23.09%

Adjusted EBITDA by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
MRD
31.44M 15.19M -1.79M -14.87M -28.08M -41.22M
Immune
4.24M 9.16M 5.36M -23.56M -24.52M -26.01M

MRD Revenue Breakdown
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Service
211.71M 192.83M 174.10M 156.28M 144.12M 133.03M 123.64M 115.84M
Service Growth
46.89% 44.96% 40.81% 34.91% 31.69% 29.48% 26.06% 24.07%
Regulatory Milestone
24.00M 19.50M 16.50M 15.00M 12.50M 12.50M 12.50M 7.50M
Regulatory Milestone Growth
92.00% 56.00% 32.00% 100.00% 177.78% - 525.00% 275.00%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.